As the race to vaccinate continues, state and federal enforcement agencies are hard at work investigating and prosecuting COVID-19-related health care fraud.
Even prior to the PHE, the U.S. Department of Justice led several significant telehealth fraud enforcement actions.
On February 1, 2021, Chief Magistrate Judge Joseph C. Spero entered final judgment in Wit v. United Behavioral Health, No. 3:14-cv-2346 (N.D. Cal.).
On August 3, 2020, the California Supreme Court held in Ixchel Pharma, LLC v. Biogen, Inc. that tortious interference with at-will contracts requires establishing wrongful conduct independent of interference itself.
The Equal Employment Opportunity Commission proposed two new regulations on January 7 applying the Americans with Disabilities Act of 1990 and the Genetic Information Nondiscrimination Act of 2008 to workplace wellness programs.
On January 5, 2021, the California Department of Managed Health Care issued an All Plan Letter regarding the newly passed California Senate Bill 855 (Wiener, Stats. 2020, ch. 151 § 2) (SB 855).
The long-awaited and hard-fought No Surprises Act was signed into law on December 27, 2020, as part of the Consolidated Appropriations Act, 2021 (Division BB, Title I, Sec. 101–118).
On November 20, 2020, the Department of Health and Human Services (HHS) published two rules that finalize sweeping reforms to the regulations governing fraud and abuse in the Medicare and Medicaid programs.
On September 30, 2020, the New York State Department of Financial Services (DFS) and Department of Health (DOH) promulgated regulations requiring health insurers operating in the state to develop and implement a mental health and substance use disorder (MH/SUD) parity compliance program.
On November 10, the Supreme Court is scheduled to hear oral arguments in California v. Texas—formerly referred to as Texas v. United States—a case challenging the constitutionality of the Affordable Care Act (ACA).